In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Efgartigimod and Rozanolixizumab.

Show references:

https://doi.org/10.1016/s1474-4422(21)00159-9

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract